Ezetimibe Improves Rosuvastatin Effects on Inflammation and Vascular Endothelial Function in Acute Coronary Syndrome Patients Undergoing PCI

Table 2

Procedural characteristics.

	Rosuvastatin (n = 90)	Ezetimibe/rosuvastatin (n = 81)	value
Vessel treated
Left anterior descending	52 (57.8)	48 (59.3)	0.84
Left circumflex	25 (27.8)	16 (19.8)	0.22
Right coronary artery	33 (36.7)	27 (33.3)	0.65
Type of intervention
Balloon only	8 (8.9)	5 (6.2)	0.50
Stent	82 (91.1)	76 (93.8)	0.50
No. of stents per patient	1.43 ± 0.63	1.26 ± 0.57	0.10
Stent diameter (mm)	2.98 ± 0.34	3.00 ± 0.34	0.83
Total stent length (mm)	30.37 ± 15.38	26.04 ± 15.29	0.08
Direct stenting, n (%)	14 (17.1)	10 (13.2)	0.49
No. of predilatations	68 (82.9)	66 (86.8)	0.49

Values are presented as n (%) or mean ± standard deviation.